YMT compared with GYRE: revenue, margins and what each company keeps, and the suppliers and customers both name

YMTYimutian Inc.

Mkt capRevenueRevenue

GYREGyre Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

YMTYimutian Inc.

GYREGyre Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

YMT

No earnings history for YMT.

GYRE

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+18.70%—

Q2 FY26±65.8%▲+4.22%×0.06

May 7 '26±42.3%▼−12.06%×0.29

Q1 FY26±56.7%▼−6.30%×0.11

= impliedYMT realized, solidGYRE realized, hatchedOne scale, both sides: full bar = 66%× = |realized| ÷ impliedSource: market data

YMTYimutian Inc.

0.26▲+2.53%· post 0.27

Mkt cap$22.3MRevenue—Revenue—

GYREGyre Therapeutics, Inc.

4.75▲+18.58%· post 4.75

ClosedNov 6 '26

Mkt cap$548.9MRevenue$33MQ3 FY26Revenue$120MFY25

Compare

ClosedNov 6 '26

YMTYimutian Inc.

GYREGyre Therapeutics, Inc.

0.26▲+2.53%post 0.27

Price

4.75▲+18.58%post 4.75

$22.3M

Mkt cap

$548.9M

—

Revenue

$33MQ3 FY26

—

Revenue

$120MFY25

YMT0.26▲+2.53%vsGYRE4.75▲+18.58%ClosedNov 6 '26